Calcium-phosphate metabolism – selected disorders in children

Elżbieta Jakubowska-Pietkiewicz

doi:10.5114/pedm.2024.146682

eISSN: 2083-8441
ISSN: 2081-237X

Pediatric Endocrinology Diabetes and Metabolism

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

Journal integrated with

4/2024
vol. 30

Send email

Copy url:

Editorial

Calcium-phosphate metabolism – selected disorders in children

Elżbieta Jakubowska-Pietkiewicz

¹

Department of Paediatrics, Neonatal Pathology and Bone Metabolic Diseases, Medical University of Lodz, Poland

Pediatr Endocrinol Diabetes Metab 2024; 30 (4): 169-173

DOI: https://doi.org/10.5114/pedm.2024.146682

Online publish date: 2025/01/27

Article file

- Editorial Calcium-phosphate.pdf [2.10 MB]

Get citation

PlumX metrics:

1. Ciosek Ż, Kot K, Kosik-Bogacka D, et al. The Effects of Calcium, Magnesium, Phosphorus, Fluoride, and Lead on Bone Tissue. Biomolecules 2021; 11: 506. doi: 10.3390/biom11040506.

2. Rout P, Jialal I. Hyperphosphatemia. In: StatPearls. Treasure Island (FL): StatPearls Publishing 2023.

3. Miller WL, Imel EA. Rickets, Vitamin D, and Ca/P Metabolism. Horm Res Paediatr 2022; 95: 579-592. doi: 10.1159/000527011.

4. Płudowski P, Kos-Kudła B, Walczak M, et al. Guidelines for Preventing and Treating Vitamin D Deficiency: A 2023 Update in Poland. Nutrients 2023; 15: 695. doi: 10.3390/nu15030695.

5. Holick MF. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 2017; 18: 153–165. doi: 10.1007/s11154-017-9424-1.

6. Alonso N, Zelzer S, Eibinger G, Herrmann M. Vitamin D Metabolites: Analytical Challenges and Clinical Relevance. Calcif Tissue Int 2023; 112: 158–177. doi: 10.1007/s00223-022-00961-5.

7. Grover M, Ashraf AP, Bowden SA, et al. Invited Mini Review Metabolic Bone Disease of Prematurity: Overview and Practice Recommendations. Horm Res Paediatr 2024. doi: 10.1159/000536228.

8. Chacham S, Pasi R, Chegondi M, et al. Metabolic Bone Disease in Premature Neonates: An Unmet Challenge. J Clin Res Pediatr Endocrinol 2020; 12: 332–339. doi: 10.4274/jcrpe.galenos.2019.2019.0091.

9. Rayannavar A, Calabria AC. Screening for Metabolic Bone Disease of prematurity. Semin Fetal Neonatal Med 2020; 25: 101086. doi: 10.1016/j.siny.2020.101086.

10. Wang J, Zhao Q, Chen B, et al. Risk factors for metabolic bone disease of prematurity: A meta-analysis. PLoS One 2022; 17: e0269180. doi: 10.1371/journal.pone.0269180.

11. Chinoy A, Padidela R. Refractory Rickets. Indian J Pediatr 2023; 90: 574–581. doi: 10.1007/s12098-023-04538-4.

12. Haffner D, Leifheit-Nestler M, Grund A, Schnabel D. Rickets guidance: part II-management. Pediatr Nephrol 2022; 37: 2289–2302. doi: 10.1007/s00467-022-05505-5.

13. Ackah SA, Imel EA. Approach to Hypophosphatemic Rickets. J Clin Endocrinol Metab 2022; 108: 209–220. doi: 10.1210/clinem/dgac488.

14. Imel EA. Burosumab for Pediatric X-Linked Hypophosphatemia. Curr Osteoporos Rep 2021; 19: 271–277. doi: 10.1007/s11914-021-00669-9.

15. Ariceta G, Beck-Nielsen SS, Boot AM, et al. The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data. Orphanet J Rare Dis 2023; 18: 304. doi: 10.1186/s13023-023-02882-4.

16. Ward LM, Weber DR, Munns CF, et al. A Contemporary View of the Definition and Diagnosis of Osteoporosis in Children and Adolescents. J Clin Endocrinol Metab 2020; 105: e2088–e2097. doi: 10.1210/clinem/dgz294.

17. Grover M, Bachrach LK. Osteoporosis in Children with Chronic Illnesses: Diagnosis, Monitoring, and Treatment. Curr Osteoporos Rep 2017; 15: 271–282. doi: 10.1007/s11914-017-0371-2.

18. Ciancia S, van Rijn RR, Högler W, et al. Osteoporosis in children and adolescents: when to suspect and how to diagnose it. Eur J Pediatr 2022; 181: 2549–2561, doi: 10.1007/s00431-022-04455-2.

19. Simm PJ, Biggin A, Zacharin MR, et al. Consensus guidelines on the use of bisphosphonate therapy in children and adolescents. J Paediatr Child Health 2018; 54: 223–233. doi: 10.1111/jpc.13768.

20. Jakubowska-Pietkiewicz E, Woźniak E, Matczak D. Rozpoznawanie osteoporozy wtórnej – wieloletnie obserwacje dzieci z przepukliną oponowo-rdzeniową i mózgowym porażeniem dziecięcym. Pediatr Med Rodz 2021; 17: 47–51.

21. Sakka SD, Cheung MS. Management of primary and secondary osteoporosis in children. Ther Adv Musculoskelet Dis 2020; 12: 1759720X20969262. doi: 10.1177/1759720X20969262.

22. Van Dijk FS, Sillence DO. Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment [published correction appears in Am J Med Genet A 2015; 167A: 1178]. Am J Med Genet A 2014; 164 A: 1470–1481. doi: 10.1002/ajmg.a.36545.

23. Marom R, Rabenhorst BM, Morello R. Osteogenesis imperfecta: an update on clinical features and therapies. Eur J Endocrinol 2020; 183: R95–R106. doi: 10.1530/EJE-20-0299.

24. Deguchi M, Tsuji S, Katsura D, et al. Current Overview of Osteogenesis Imperfecta. Medicina (Kaunas) 2021; 57: 464. doi: 10.3390/medicina57050464.

25. Jakubowska-Pietkiewicz E, Górczewska B, Nowicki J, et al. Assessment of the health status and farmacological treatment of neonates with osteogenesis imperfecta-20-years single-centre observations. Pediatr Med Rodz 2023; 19: 389–397.

26. Arundel P, Borg SA. Early Life Management of Osteogenesis Imperfecta. Curr Osteoporos Rep 2023; 21: 779–786. doi: 10.1007/s11914-023-00823-5.

Calcium-phosphate metabolism – selected disorders in children

Elżbieta Jakubowska-Pietkiewicz 1

Elżbieta Jakubowska-Pietkiewicz

¹